Over and back.

Recent News

Wedbush Goes Old School with Analog Economy ETF

Photo by Getty Images via Unsplash

2 min read
For Sale: What Asset Managers Want in Indie ETF Shops

Photo by Ruliff Andrean via Unsplash

2 min read
Can Alibaba Become a Serious Hyperscaler?

Photo via IMAGO/VCG/Newscom

1 min read

JUST FOR FUN

Over and back.

The physics of this 'snake shot' by Sweden's Truls Möregårdh in table tennis at the Olympics finalpic.twitter.com/KLzIMZpM1d
— Massimo (@Rainmaker1973) August 5, 2024

Photo via IMAGO/Ulrich Roth/Newscom

Healthcare

Viking Therapeutics Soars as Weight-Loss Drug Trial Addresses GLP-1 Weakness

Research has shown the adherence rates of patients on GLP-1 therapies can fall as low as 27% after one year.

2 min read
Photo via Bianca Otero/ZUMAPRESS/Newscom

Banking

Goldman Leads Bidding for $37 Billion Palmer Square, a CLO Powerhouse

CLOs allow investors to potentially get higher-than-average returns in exchange for taking on greater default risk.

2 min read

Photo via Damon Butler

Financial Planning

The Next Chapter of Active Investing

5 min watch
Photo by Louis Velazquez via Unsplash

Advisor Upside

Do Employees Even Want Alts in 401(k)s?

Some lawmakers are questioning whether the majority of demand is coming from investors or the industry.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.

Recent News

Wedbush Goes Old School with Analog Economy ETF

For Sale: What Asset Managers Want in Indie ETF Shops

Can Alibaba Become a Serious Hyperscaler?

Over and back.

Viking Therapeutics Soars as Weight-Loss Drug Trial Addresses GLP-1 Weakness

Goldman Leads Bidding for $37 Billion Palmer Square, a CLO Powerhouse

Sports Betting Looks for a Parlay Into Funds

Finding Opportunity in a Shifting Investment Landscape

The Next Chapter of Active Investing

Do Employees Even Want Alts in 401(k)s?

Sign Up for The Daily Upside to Unlock This Article